AKT1 and kidney cancer: Several predictions involved mutations in genes functionally associated with PIK3CA-AKT1 signalling (including PTENmut in kidney cancer, LATS2mut in lung adenocarcinoma and PIK3CGmut in uterine cancer), suggesting that the method identifies biologically meaningful biomarkers (Fig. 4e).